160 related articles for article (PubMed ID: 9057422)
1. Intravenous alpha-1-antitrypsin replacement therapy: case report after one year of treatment.
Ward AC; Keogh BA
Ir J Med Sci; 1997; 166(1):7-9. PubMed ID: 9057422
[TBL] [Abstract][Full Text] [Related]
2. [The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency].
Manresa F
Arch Bronconeumol; 1995; 31(7):371-2. PubMed ID: 8777536
[No Abstract] [Full Text] [Related]
3. Alpha-1-antitrypsin and other proteinase inhibitors.
Miravitlles M
Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
[TBL] [Abstract][Full Text] [Related]
4. α1-Antitrypsin Deficiency.
Hatipoğlu U; Stoller JK
Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
[TBL] [Abstract][Full Text] [Related]
5. Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.
Schwaiblmair M; Vogelmeier C; Fruhmann G
Respiration; 1997; 64(1):10-5. PubMed ID: 9044469
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
Balbi B; Ferrarotti I; Miravitlles M
Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
[No Abstract] [Full Text] [Related]
7. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antitrypsin replacement therapy: current status.
Abusriwil H; Stockley RA
Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
[TBL] [Abstract][Full Text] [Related]
9. Antiproteinase deficiency, emphysema and replacement therapy.
Burdon JG; Knight KR; Brenton S; Cook L
Aust N Z J Med; 1996 Dec; 26(6):769-71. PubMed ID: 9028505
[No Abstract] [Full Text] [Related]
10. [Evaluation after 2 years of substitutive treatment of PiZZ emphysema with alpha-1 antitrypsin. 9 cases].
Carles P; Constans J; Pujazon MC; Arnaud J; Lauque D; Goudemand M
Presse Med; 1990 Mar; 19(11):514-8. PubMed ID: 2138750
[TBL] [Abstract][Full Text] [Related]
11. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin augmentation therapy.
Wewers MD; Crystal RG
COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
[TBL] [Abstract][Full Text] [Related]
13. Augmentation therapy in alpha-1 antitrypsin deficiency.
Heresi GA; Stoller JK
Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
[TBL] [Abstract][Full Text] [Related]
14. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
Sandhaus RA
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
[TBL] [Abstract][Full Text] [Related]
15. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR;
Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480
[TBL] [Abstract][Full Text] [Related]
17. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
Chiuchiolo MJ; Crystal RG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
[TBL] [Abstract][Full Text] [Related]
18. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
[TBL] [Abstract][Full Text] [Related]
19. Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.
Campos M; Lascano J
Methods Mol Biol; 2017; 1639():249-262. PubMed ID: 28752465
[TBL] [Abstract][Full Text] [Related]
20. The potential role of elastase inhibitors in emphysema treatment.
Eriksson S
Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
[No Abstract] [Full Text] [Related]
[Next] [New Search]